Feeling like the days of wishing and hoping for a a PR with
Feeling like the days of wishing and hoping for a a PR with some sort of good news but not a clue as to when it will come are behind us.
We have a better idea of what to expect moving forward. The first and most urgent step now is the mtg with the EMA to get their input so that we can finalize protocol for OM P3. Prior to this meeting no news from IPIX can be expected IMO and that is fine with me.
I expect we get a PR after this mtg has occurred and we get positive feedback from EMA and feel we can incorporate everything required by the FDA/EMA into a P3 as stockholders deserve to be kept somewhat in the loop as to what is progressing w/ the company.
What is still a bit murky to me is when IPIX will sign a partnership for B-OM and if they are ready to announce same prior to submitting and receiving an OK for the P3 from both the FDA and EMA. Hope BP is ready to sign deal as soon as we get positive news we can proceed w/ P3 in both USA and Europe and we can announce a substantial upfront payment to be able to get some cash in our coffers.
As to IBD, I have no clue if that is actively being discussed now or if a partnership for that is predicated on successful pill formulation.
Regarding another bridge financing play and dilution to put us in a better position for IBD deal, if it has to be it has to be. Most of us can pick up shares now at low, low prices to make up for the dilution so that mitigates the payback expectations for many due to the further dilution.
I don't expect any news this week, except for possible further financing deal filing. I can live with another few weeks for EMA to get it all together as everything seems to be on a good track and with some cash we can again get hitting on all cylinders with further efforts (if enough cash) to pill formulations for B and K, topical creams for B dermatology indications, and a final end to further dilution to keep the doors open.
Price may get whacked for another couple of weeks, but the end game will make it all worthwhile IMO. Many think we are really sucking wind but the tale of the tape shows the real desperation at this time is on the side of those betting against the company.
These are all my WAGs as to upcoming events, no basis in fact or anything I have heard recently. Overall, though, those I talk to are all on the same page and that is the page loaded with confidence in the future of IPIX.
10
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Reimagining Streaming: GRAI Buys Hangout FM The music streaming game has just been dealt a fresh hand. GRAI, an AI-driven music company, has snatched up Hangout FM, looking to ignite a social revolution in how we experience music. Sitting here, I'm thinking about all those playlists we've built but never truly shared. This acquisition might just change that by combining...
Continue Reading
Pioneering Leadership for Children's Brain Tumor Network In a world where every advance in pediatric oncology can make a measurable difference, the Children's Brain Tumor Network (CBTN) has just unveiled quite the ace up its sleeve: Dr. Sarah Leary. She's stepping in as Co-Chair of its Executive Board, taking the reins alongside Brian Rood, MD. With extensive experience...
Continue Reading
Changing the AI Game in Enterprise At the heart of Tel Aviv-Yafo, ABnet Communication Ltd. is spitting fire, and this ain't your average tech chatter. They're drilling right down to the marrow, stressing just how much Anthropic—kingpin of advanced AI for enterprises—is shaking up the corporate shell game. Today’s conversation leans heavily into autonomous AI, and...
Continue Reading
Remember the days when the FBI felt like a mythical fortress of surveillance and high-tech wizardry? Today, we're seeing one of its key veterans, Marcus Thomas, take a different path—a path that's as gritty and necessary as any Wall Street hustle. He's jumping onto the board of Re-fined, a Denver nonprofit aiming to give survivors of sexual exploitation and human...
Continue Reading
iFranchise's Unyielding Dominance in Franchise Consulting Five seconds in the franchise game, and you'd know that staying on top is a grind. But when you're iFranchise Group, it seems like the eighth time is the charm—if there ever was a need for luck. These folks have secured the number one spot in Entrepreneur magazine's Top Franchise Suppliers ranking yet again....
Continue Reading
Unifying Molecular Diagnostics for Better Cancer Care In the chaos of today’s healthcare, Aranscia is aiming to rewrite the book on how we handle cancer diagnostics by teaming up with Northside Hospital Cancer Institute. Now, instead of fumbling through disconnected systems, they plan to glue the pieces together with a blend of their own and borrowed tech. This...
Continue Reading
A Fresh Start for Young Careers with CareerPath You remember the time in life when we thought just having a degree meant something? Well, the game’s changed, and now it’s a twisted jungle where young folks struggle to find their footing. Partners International, a name I’m no stranger to—known for their human capital wizardry—seems to have noticed this chaotic...
Continue Reading
Bringing New Leadership to Charter Next Generation It's an intriguing time to be watching Charter Next Generation (CNG) as they just added a heavyweight to their executive team. Todd Herndon, a veteran with more than three decades of financial savvy, steps in as their new Chief Financial Officer. This is like a football team drafting a star quarterback right before the...
Continue Reading
CEER's Ambitious Leap in Automotive Innovation There's a new kid on the automotive block, and it's making some serious noise. Straight out of Jeddah, CEER has just taken the wraps off their flagship electric sedan and SUV, dubbed the EXOBOT. No small beans here—this is a full-throttle, Saudi-driven pitch into the global automotive circus. And why not? There's oil in...
Continue Reading
Shaking Up the Job Market with AI Skills What's shaking things up this time around? Handshake's dramatic unveiling of its AI Skills Studio, that's what. While the world spins on its financial axis, Handshake's showing up with a toolkit that's not just geeky gobbledygook. They're dead set on prepping job seekers with the nitty-gritty of AI know-how hosted in a rather...
Continue Reading
Top 5 Most Recently Viewed Articles
PureHealth Research Unveils New Ashwagandha Supplement As research highlights a significant connection between chronic stress and adverse health effects, including cognitive decline, PureHealth Research is stepping forward with a groundbreaking solution. The company has recently launched its doctor-approved Ashwagandha supplement, targeted at individuals grappling with...
Continue Reading
Captain D's Expands Internationally with New Restaurant Recently, Captain D's, the well-known American seafood and chicken restaurant, launched its first European outlet in Broadstairs, Kent. The brand's opening day was bustling, with over 1,500 guests flocking to Westwood Cross Shopping Centre to experience its celebrated Southern-style seafood offerings. Culinary...
Continue Reading
USA Rare Earth Secures Significant Funding for Expansion USA Rare Earth, Inc. (Nasdaq: USAR) has made headlines with its recent announcement of a $75 million private investment in public equity (PIPE). This major funding initiative marks a pivotal moment for the company as it seeks to bolster its operations and expand its manufacturing capabilities. Details of the Funding...
Continue Reading
WM Technology Under Scrutiny for Alleged Violations Bragar Eagel & Squire, P.C., a respected law firm known for advocating investor rights, is currently investigating claims involving WM Technology, Inc. This inquiry aims to seek answers for stockholders regarding potential violations of securities laws by the company. Understanding the Investigation The firm has...
Continue Reading
Lotus Technology Inc. Files Important Annual Report Lotus Technology Inc. (Nasdaq: LOT), a leader in the realm of intelligent luxury mobility, has recently completed a significant milestone by filing its annual report on Form 20-F with the Securities and Exchange Commission. This report pertains to the company's financial performance for the fiscal year ended December 31,...
Continue Reading